Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

John Breitner; Pierre Francois Meyer

doi:10.1212/WNL.0000000000009185

Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

John Breitner, Pierre Francois Meyer

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	593-594
Number of pages	2
Journal	Neurology
Volume	94
Issue number	13
DOIs	https://doi.org/10.1212/WNL.0000000000009185
State	Published - Mar 31 2020

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000009185

Cite this

@article{66fd5dd490b147fcb5d26633f8ff83b6,

title = "Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease",

author = "John Breitner and Meyer, {Pierre Francois}",

year = "2020",

month = mar,

day = "31",

doi = "10.1212/WNL.0000000000009185",

language = "English (US)",

volume = "94",

pages = "593--594",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "13",

}

TY - JOUR

T1 - Author response

T2 - INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

AU - Breitner, John

AU - Meyer, Pierre Francois

PY - 2020/3/31

Y1 - 2020/3/31

UR - http://www.scopus.com/inward/record.url?scp=85086842641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086842641&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000009185

DO - 10.1212/WNL.0000000000009185

M3 - Comment/debate

C2 - 32229636

AN - SCOPUS:85086842641

SN - 0028-3878

VL - 94

SP - 593

EP - 594

JO - Neurology

JF - Neurology

IS - 13

ER -

Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this